elenolic acid

Elenolic acid is an olive-derived bioactive small molecule currently in preclinical development for the treatment of obesity and type 2 diabetes. It functions as a metabolic regulator that reduces food intake and improves glucose homeostasis, demonstrating significant efficacy in diet-induced obesity and postmenopausal metabolic dysfunction models. Research indicates that elenolic acid acts as a multi-target agent, primarily by stimulating the secretion of metabolic gut hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Preclinical studies have shown that elenolic acid can enhance the weight loss and glycemic control effects of established therapies like liraglutide and metformin, supporting its potential as both a monotherapy and an adjunct strategy for metabolic disease management.